Skip to search formSkip to main contentSkip to account menu

aminoflavone

Known as: 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Flavonoids

Narrower (1)

NSC 686288

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract 4983: Aminoflavone acts as an immunomodulator of tumor growth in a breast cancer mouse model
Aminoflavone (AFP464, NSC 710464), an antitumor agent which recently entered phase II clinical trials, acts against estrogen… 
Review
2012
Review
2012
Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings
Introduction: Target-specific drugs may offer fewer side/adverse effects in comparison with other anticancer agents and thus save… 
2010
2010
Association of Human Cytochrome P450 1A1 (CYP1A1) and Sulfotransferase 1A1 (SULT1A1) Polymorphisms with Differential Metabolism and Cytotoxicity of Aminoflavone
Aminoflavone (AF), a clinically investigational novel anticancer agent, requires sequential metabolic activation by CYP1A1 and… 
2010
2010
Phase I accelerated dose-escalating safety and pharmacokinetic (PK) study of aryl-hydrocarbon receptor-mediated aminoflavone prodrug AFP464 in advanced solid tumors.
2561 Background: AFP464 is a dimethanesulfonate derivative of aminoflavone that has strong anti-tumor activity against a variety… 
2009
2009
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate aminoflavone (NSC 686288) in human plasma.
2008
2008
Cytokeratin-RNA Cross-Linking Mediated by the Antitumor Aminoflavone, 5-Amino-2,3-fluorophenyl-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one
Aminoflavone (AF) is an anticancer drug in early clinical trials, and its antiproliferative activity involves the induction of… 
2008
2008
Cytokeratin-RNA crosslinking mediated by the antitumor aminoflavone, NSC 686288
3283 Aminoflavone (AF) is an anticancer drug in early clinical trials, and its antiproliferative activity involves the induction… 
2007
2007
Breast cancer cells resistant to anti-hormone treatments retain sensitivity to Aminoflavone (NSC 686288)
PR-4 Aminoflavone (AF; NSC 686288) is a novel anticancer agent which has entered phase I clinical trials. AF has shown exquisite… 
2006
2006
CYP1A1 activation of aminoflavone leads to DNA damage in human tumor cell lines
Purpose: Aminoflavone (5-amino-2,3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one; AF; NSC 686288) is a novel… 
2004
2004
Sensitivity of renal cell carcinoma to aminoflavone: role of CYP1A1.
PURPOSE The aminoflavone analogue (AF) exhibits antitumor activity in vitro, particularly against neoplastic cells of renal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)